This article is more than 5 years old. Information may no longer be current.
CMS to reimburse VisionCare’s implantable miniature telescope
Click Here to Manage Email Alerts
VisionCare Ophthalmic Technologies has announced that the Centers for Medicare and Medicaid Services will reimburse the company’s implantable miniature telescope under a revised Ambulatory Payment Classification designation, according to VisionCare press release.
Previously, telescope implantation procedures were restricted to hospitals due to reimbursement rules, according to the release.
The new designation, APC 0351, Level V Intraocular Procedures, will take effect Jan. 1, 2015, and is part of CMS’ CY 2015 Hospital Outpatient Prospective Payment System and the Ambulatory Surgery Center Payment System final rule.
Reimbursement payment levels are expected to increase overall, and ASC payment levels will be comparable to those paid to hospital outpatient departments, according to the press release.
At the American Academy of Ophthalmology meeting in Chicago, Chet Kumar, vice president of sales and market development for VisionCare Ophthalmic Technologies, spoke with Ocular Surgery News regarding the expanded indication of the CentraSight implantable telescope for patients with late-stage age-related macular degeneration in patients 65 years and older. Watch the video.